275 related articles for article (PubMed ID: 19540933)
1. 2-methoxyestradiol attenuates bleomycin-induced pulmonary hypertension and fibrosis in estrogen-deficient rats.
Tofovic SP; Zhang X; Jackson EK; Zhu H; Petrusevska G
Vascul Pharmacol; 2009; 51(2-3):190-7. PubMed ID: 19540933
[TBL] [Abstract][Full Text] [Related]
2. 2-Methoxyestradiol mediates the protective effects of estradiol in monocrotaline-induced pulmonary hypertension.
Tofovic SP; Zhang X; Jackson EK; Dacic S; Petrusevska G
Vascul Pharmacol; 2006 Dec; 45(6):358-67. PubMed ID: 16872912
[TBL] [Abstract][Full Text] [Related]
3. Estradiol metabolites attenuate monocrotaline-induced pulmonary hypertension in rats.
Tofovic SP; Salah EM; Mady HH; Jackson EK; Melhem MF
J Cardiovasc Pharmacol; 2005 Oct; 46(4):430-7. PubMed ID: 16160593
[TBL] [Abstract][Full Text] [Related]
4. 2-Ethoxyestradiol is antimitogenic and attenuates monocrotaline-induced pulmonary hypertension and vascular remodeling.
Tofovic SP; Zhang X; Zhu H; Jackson EK; Rafikova O; Petrusevska G
Vascul Pharmacol; 2008; 48(4-6):174-83. PubMed ID: 18373958
[TBL] [Abstract][Full Text] [Related]
5. 2-Methoxyestradiol Attenuates the Development and Retards the Progression of Hypoxia-And Alpha-Naphthylthiourea-Induced Pulmonary Hypertension.
Tofovic SP; Zhang X; Jones TJ; Petruševska G
Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2021 Apr; 42(1):41-51. PubMed ID: 33894125
[TBL] [Abstract][Full Text] [Related]
6. Dose-dependent therapeutic effects of 2-Methoxyestradiol on Monocrotaline-Induced pulmonary hypertension and vascular remodelling.
Tofovic SP; Jones T; Petrusevska G
Prilozi; 2010; 31(1):279-95. PubMed ID: 20693947
[TBL] [Abstract][Full Text] [Related]
7. Progesterone inhibits vascular remodeling and attenuates monocrotaline-induced pulmonary hypertension in estrogen-deficient rats.
Tofovic PS; Zhang X; Petrusevska G
Prilozi; 2009 Jul; 30(1):25-44. PubMed ID: 19736529
[TBL] [Abstract][Full Text] [Related]
8. Synergistic therapeutic effects of 2-methoxyestradiol with either sildenafil or bosentan on amelioration of monocrotaline-induced pulmonary hypertension and vascular remodeling.
Tofovic SP; Jones TJ; Bilan VP; Jackson EK; Petrusevska G
J Cardiovasc Pharmacol; 2010 Nov; 56(5):475-83. PubMed ID: 20881615
[TBL] [Abstract][Full Text] [Related]
9. Estrogens and development of pulmonary hypertension: interaction of estradiol metabolism and pulmonary vascular disease.
Tofovic SP
J Cardiovasc Pharmacol; 2010 Dec; 56(6):696-708. PubMed ID: 20881610
[TBL] [Abstract][Full Text] [Related]
10. Severe pulmonary hypertension in aging female apolipoprotein E-deficient mice is rescued by estrogen replacement therapy.
Umar S; Partow-Navid R; Ruffenach G; Iorga A; Moazeni S; Eghbali M
Biol Sex Differ; 2017; 8():9. PubMed ID: 28344760
[TBL] [Abstract][Full Text] [Related]
11. The potential protective effects of estradiol and 2-methoxyestradiol in ischemia reperfusion-induced kidney injury in ovariectomized female rats.
Hassan E; Allam S; Mansour AM; Shaheen A; Salama SA
Life Sci; 2022 May; 296():120441. PubMed ID: 35240160
[TBL] [Abstract][Full Text] [Related]
12. Effects of simvastatin on pulmonary fibrosis, pulmonary hypertension and exercise capacity in bleomycin-treated rats.
Schroll S; Lange TJ; Arzt M; Sebah D; Nowrotek A; Lehmann H; Wensel R; Pfeifer M; Blumberg FC
Acta Physiol (Oxf); 2013 Jun; 208(2):191-201. PubMed ID: 23527830
[TBL] [Abstract][Full Text] [Related]
13. Estradiol metabolites attenuate renal and cardiovascular injury induced by chronic nitric oxide synthase inhibition.
Tofovic SP; Salah EM; Dubey RK; Melhem MF; Jackson EK
J Cardiovasc Pharmacol; 2005 Jul; 46(1):25-35. PubMed ID: 15965351
[TBL] [Abstract][Full Text] [Related]
14. Estradiol improves right ventricular function in rats with severe angioproliferative pulmonary hypertension: effects of endogenous and exogenous sex hormones.
Frump AL; Goss KN; Vayl A; Albrecht M; Fisher A; Tursunova R; Fierst J; Whitson J; Cucci AR; Brown MB; Lahm T
Am J Physiol Lung Cell Mol Physiol; 2015 May; 308(9):L873-90. PubMed ID: 25713318
[TBL] [Abstract][Full Text] [Related]
15. Long-term treatment with fasudil improves bleomycin-induced pulmonary fibrosis and pulmonary hypertension via inhibition of Smad2/3 phosphorylation.
Bei Y; Hua-Huy T; Duong-Quy S; Nguyen VH; Chen W; Nicco C; Batteux F; Dinh-Xuan AT
Pulm Pharmacol Ther; 2013 Dec; 26(6):635-43. PubMed ID: 23928001
[TBL] [Abstract][Full Text] [Related]
16. Early treatment with fumagillin, an inhibitor of methionine aminopeptidase-2, prevents Pulmonary Hypertension in monocrotaline-injured rats.
Kass DJ; Rattigan E; Kahloon R; Loh K; Yu L; Savir A; Markowski M; Saqi A; Rajkumar R; Ahmad F; Champion HC
PLoS One; 2012; 7(4):e35388. PubMed ID: 22509410
[TBL] [Abstract][Full Text] [Related]
17. Gender-based differences in bleomycin-induced pulmonary fibrosis.
Gharaee-Kermani M; Hatano K; Nozaki Y; Phan SH
Am J Pathol; 2005 Jun; 166(6):1593-606. PubMed ID: 15920145
[TBL] [Abstract][Full Text] [Related]
18. Beta-estradiol attenuates hypoxic pulmonary hypertension by stabilizing the expression of p27kip1 in rats.
Xu DQ; Luo Y; Liu Y; Wang J; Zhang B; Xu M; Wang YX; Dong HY; Dong MQ; Zhao PT; Niu W; Liu ML; Gao YQ; Li ZC
Respir Res; 2010 Dec; 11(1):182. PubMed ID: 21182801
[TBL] [Abstract][Full Text] [Related]
19. Pan-PPAR agonist IVA337 is effective in experimental lung fibrosis and pulmonary hypertension.
Avouac J; Konstantinova I; Guignabert C; Pezet S; Sadoine J; Guilbert T; Cauvet A; Tu L; Luccarini JM; Junien JL; Broqua P; Allanore Y
Ann Rheum Dis; 2017 Nov; 76(11):1931-1940. PubMed ID: 28801346
[TBL] [Abstract][Full Text] [Related]
20. Reverse right ventricular structural and extracellular matrix remodeling by estrogen in severe pulmonary hypertension.
Nadadur RD; Umar S; Wong G; Eghbali M; Iorga A; Matori H; Partow-Navid R; Eghbali M
J Appl Physiol (1985); 2012 Jul; 113(1):149-58. PubMed ID: 22628376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
